본문 바로가기
KERD
논문KCI 미등재

Cryo-EM as a powerful tool for drug discovery: recent structural based studies of SARS-CoV-2

정현석|Kim Han-ul
한국현미경학회 (Korean Society Of Microscopy)|2021.09|Applied Microscopy|제51권 제3호|pp. 1-7|DOI 10.1186/s42649-021-00062-x

2

조회

0

다운로드

1

인용

0

참고문헌

주제분류자연과학일반

초록

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has arisen as a global pandemic affecting the respiratory system showing acute respiratory distress syndrome (ARDS). However, there is no targeted therapeutic agent yet and due to the growing cases of infections and the rising death tolls, discovery of the possible drug is the need of the hour. In general, the study for discovering therapeutic agent for SARS-CoV-2 is largely focused on large-scale screening with fragment-based drug discovery (FBDD). With the recent advancement in cryo-electron microscopy (Cryo-EM), it has become one of the widely used tools in structural biology. It is effective in investigating the structure of numerous proteins in high-resolution and also had an intense influence on drug discovery, determining the binding reaction and regulation of known drugs as well as leading the design and development of new drug candidates. Here, we review the application of cryo-EM in a structure-based drug design (SBDD) and in silico screening of the recently acquired FBDD in SARS-CoV-2. Such insights will help deliver better understanding in the procurement of the effective remedial solution for this pandemic.

Abstract

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has arisen as a global pandemic affecting the respiratory system showing acute respiratory distress syndrome (ARDS). However, there is no targeted therapeutic agent yet and due to the growing cases of infections and the rising death tolls, discovery of the possible drug is the need of the hour. In general, the study for discovering therapeutic agent for SARS-CoV-2 is largely focused on large-scale screening with fragment-based drug discovery (FBDD). With the recent advancement in cryo-electron microscopy (Cryo-EM), it has become one of the widely used tools in structural biology. It is effective in investigating the structure of numerous proteins in high-resolution and also had an intense influence on drug discovery, determining the binding reaction and regulation of known drugs as well as leading the design and development of new drug candidates. Here, we review the application of cryo-EM in a structure-based drug design (SBDD) and in silico screening of the recently acquired FBDD in SARS-CoV-2. Such insights will help deliver better understanding in the procurement of the effective remedial solution for this pandemic.

참고문헌 (79)

  1. K. Ravi Acharya, "The advantages and limitations of protein crystal structures", Trends in Pharmacological Sciences, 26(1), pp.10~14 (2005), Elsevier BV[DOI]
  2. Pavel V. Afonine, "Real-space refinement in PHENIX for cryo-EM and crystallography", Acta Crystallographica Section D Structural Biology, 74(6), pp.531~544 (2018), International Union of Crystallography (IUCr)[DOI]
  3. Ayumu Asai, "COVID-19 Drug Discovery Using Intensive Approaches", International Journal of Molecular Sciences, 21(8), pp.2839~ (2020), MDPI AG[DOI]
  4. K. A. Baker, "Structural basis for paramyxovirus- mediated membrane fusion", Mol. Cell, 3(3), pp.309~319 (1999)[DOI]
  5. James M. Bell, "New software tools in EMAN2 inspired by EMDatabank map challenge", Journal of Structural Biology, 204(2), pp.283~290 (2018), Elsevier BV[DOI]
  6. H. J. Berendsen, "Collective protein dynamics in relation to function", Curr. Opin. Struct. Biol., 10(2), pp.165~169 (2000)[DOI]
  7. Subramanian Boopathi, "Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment", Journal of Biomolecular Structure and Dynamics, pp.1~10 (2020), Informa UK Limited[DOI]
  8. B. J. Bosch, "The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex", J. Virol., 77(16), pp.8801~8811 (2003)[DOI]
  9. Yongfei Cai, "Distinct conformational states of SARS-CoV-2 spike protein", Science, 369(6511), pp.1586~1592 (2020), American Association for the Advancement of Science (AAAS)[DOI]
  10. Leon Caly, "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro", Antiviral Research, 178, pp.104787~ (2020), Elsevier BV[DOI]
  11. Z. Chagla, "The BNT162b2 (BioNTech", Pfizer) vaccine had 95% efficacy against COVID-19 >, Ann. Intern. Med., pp.2021, 174(2)[DOI]
  12. N. Chazal, "Virus entry, assembly, budding, and membrane rafts", Microbiol. Mol. Biol. Rev., 67(2), pp.226~237 (2003)[DOI]
  13. T. F. Chen, "DockCoV2: a drug database against SARS-CoV-2", Nucleic Acids Res, 49(D1), pp.D1152~D1159 (2021)
  14. Shweta Choudhary, "Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach", Frontiers in Immunology, 11 (2020), Frontiers Media SA[DOI]
  15. Bruce D. Dorsey, "L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor", Journal of Medicinal Chemistry, 37(21), pp.3443~3451 (1994), American Chemical Society (ACS)[DOI]
  16. Anna Dubrovsky, "Developments in cryo-electron tomography for in situ structural analysis", Archives of Biochemistry and Biophysics, 581, pp.78~85 (2015), Elsevier BV[DOI]
  17. Edward H. Egelman, "The Current Revolution in Cryo-EM", Biophysical Journal, 110(5), pp.1008~1012 (2016), Elsevier BV[DOI]
  18. S Ekins, "In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling", British Journal of Pharmacology, 152(1), pp.9~20 (2007), Wiley[DOI]
  19. John Erickson, "Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 Protease", Science, 249(4968), pp.527~533 (1990), American Association for the Advancement of Science (AAAS)[DOI]
  20. D.A. Erlanson, "Many small steps towards a COVID-19 drug", Nat. Commun., 11(1), pp.5048~ (2020)[DOI]
  21. Joachim Frank, "Advances in the field of single-particle cryo-electron microscopy over the last decade", Nature Protocols, 12(2), pp.209~212 (2017), Springer Science and Business Media LLC[DOI]
  22. S GHOSH, "Structure-based virtual screening of chemical libraries for drug discovery", Current Opinion in Chemical Biology, 10(3), pp.194~202 (2006), Elsevier BV[DOI]
  23. B. S. Graham, "Structure-based vaccine antigen design", Annu. Rev. Med, 70, pp.91~104 (2019)[DOI]
  24. Timothy Grant, "cisTEM, user-friendly software for single-particle image processing", eLife, 7 (2018), eLife Sciences Publications, Ltd[DOI]
  25. Mahmoud A.A. Ibrahim, "In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors", Computers in Biology and Medicine, 126, pp.104046~ (2020), Elsevier BV[DOI]
  26. Y. P. Jiang, "Drug screening and development from the affinity of S protein of new coronavirus with ACE2", Eur. J. Clin. Microbiol. Infect. Dis., 40(4), pp.715~723 (2021)[DOI]
  27. Sebastian Jojoa-Cruz, "Cryo-EM structure of the mechanically activated ion channel OSCA1.2", eLife, 7 (2018), eLife Sciences Publications, Ltd[DOI]
  28. Domen Kampjut, "Cryo-EM grid optimization for membrane proteins", iScience, 24(3), pp.102139~ (2021), Elsevier BV[DOI]
  29. Megan L. Kelly, "Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem–loop RNAs and their implications for functional cellular assays", RNA, 27(1), pp.12~26 (2020), Cold Spring Harbor Laboratory[DOI]
  30. R. N. Kirchdoerfer, "Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis", Sci. Rep., 8(1), pp.15701~ (2018)[DOI]
  31. Douglas B. Kitchen, "Docking and scoring in virtual screening for drug discovery: methods and applications", Nature Reviews Drug Discovery, 3(11), pp.935~949 (2004), Springer Science and Business Media LLC[DOI]
  32. M.D. Knoll, "Oxford-AstraZeneca COVID-19 vaccine efficacy", Lancet, 397(10269), pp.72~74 (2021)[DOI]
  33. Werner Kühlbrandt, "The Resolution Revolution", Science, 343(6178), pp.1443~1444 (2014), American Association for the Advancement of Science (AAAS)[DOI]
  34. Eunju Kwon, "Structural insights into stressosome assembly", IUCrJ, 6(5), pp.938~947 (2019), International Union of Crystallography (IUCr)[DOI]
  35. Chih-Cheng Lai, "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges", International Journal of Antimicrobial Agents, 55(3), pp.105924~ (2020), Elsevier BV[DOI]
  36. Andrew R. Leach, "Prediction of Protein−Ligand Interactions. Docking and Scoring:  Successes and Gaps", Journal of Medicinal Chemistry, 49(20), pp.5851~5855 (2006), American Chemical Society (ACS)[DOI]
  37. F. Li, "Structure, function, and evolution of coronavirus spike proteins", Annu. Rev. Virol., 3(1), pp.237~261 (2016)[DOI]
  38. Jian Li, "Application of X-ray Diffraction and Electron Crystallography for Solving Complex Structure Problems", Accounts of Chemical Research, 50(11), pp.2737~2745 (2017), American Chemical Society (ACS)[DOI]
  39. C. Liu, "Viral architecture of SARS-CoV-2 with post-fusion spike revealed by Cryo-EM", bioRxiv. 2020.2003.2002.972927, ~ (2020)
  40. Elisabeth Mahase, "Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows", BMJ, pp.m4471~ (2020), BMJ[DOI]
  41. Laurent Maveyraud, "Protein X-ray Crystallography and Drug Discovery", Molecules, 25(5), pp.1030~ (2020), MDPI AG[DOI]
  42. Alan Merk, "Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery", Cell, 165(7), pp.1698~1707 (2016), Elsevier BV[DOI]
  43. undefined, "Method of the Year 2015", Nature Methods, 13(1), pp.1~1 (2016), Springer Science and Business Media LLC[DOI]
  44. Ziyad Tariq Muhseen, "Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach", Journal of Molecular Liquids, 320, pp.114493~ (2020), Elsevier BV[DOI]
  45. T. Nakane, "Single-particle cryo-EM at atomic resolution", Nature, 587(7832), pp.152~156 (2020)[DOI]
  46. Eva Nogales, "The development of cryo-EM into a mainstream structural biology technique", Nature Methods, 13(1), pp.24~27 (2016), Springer Science and Business Media LLC[DOI]
  47. Jesper Pallesen, "Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen", Proceedings of the National Academy of Sciences, 114(35), pp.E7348~E7357 (2017), Proceedings of the National Academy of Sciences[DOI]
  48. An Pan, "Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China", JAMA, 323(19), pp.1915~ (2020), American Medical Association (AMA)[DOI]
  49. Y. Pan, "Structural basis of ion transport and inhibition in ferroportin", Nat. Commun, 11(1), pp.5686~ (2020)[DOI]
  50. Pritam Kumar Panda, "Structure-based drug designing and immunoinformatics approach for SARS-CoV-2", Science Advances, 6(28) (2020), American Association for the Advancement of Science (AAAS)[DOI]
  51. Eric F. Pettersen, "UCSF Chimera?A visualization system for exploratory research and analysis", Journal of Computational Chemistry, 25(13), pp.1605~1612 (2004), Wiley[DOI]
  52. Anastasiia I. Petushkova, "Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations", Pharmaceuticals, 13(10), pp.277~ (2020), MDPI AG[DOI]
  53. Ali Punjani, "cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination", Nature Methods, 14(3), pp.290~296 (2017), Springer Science and Business Media LLC[DOI]
  54. S. Rawson, "Methods to account for movement and flexibility in cryo-EM data processing", Methods, 100, pp.35~41 (2016), Elsevier BV[DOI]
  55. Jean-Paul Renaud, "Cryo-EM in drug discovery: achievements, limitations and prospects", Nature Reviews Drug Discovery, 17(7), pp.471~492 (2018), Springer Science and Business Media LLC[DOI]
  56. L. Riva, "Discovery of SARS-CoV-2 antiviral drugs through largescale compound repurposing", Nature, 586(7827), pp.113~119 (2020)[DOI]
  57. Noel A. Roberts, "Rational Design of Peptide-Based HIV Proteinase Inhibitors", Science, 248(4953), pp.358~361 (1990), American Association for the Advancement of Science (AAAS)[DOI]
  58. Didier Rognan, "The impact of in silico screening in the discovery of novel and safer drug candidates", Pharmacology & Therapeutics, 175, pp.47~66 (2017), Elsevier BV[DOI]
  59. Alexis Rohou, "CTFFIND4: Fast and accurate defocus estimation from electron micrographs", Journal of Structural Biology, 192(2), pp.216~221 (2015), Elsevier BV[DOI]
  60. Giovanna Scapin, "Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application", Cell Chemical Biology, 25(11), pp.1318~1325 (2018), Elsevier BV[DOI]
  61. S.H. Scheres, "Processing of structurally heterogeneous cryo-EM data in RELION", Methods Enzymol, 579, pp.125~157 (2016)[DOI]
  62. Claudio Schmidli, "Microfluidic protein isolation and sample preparation for high-resolution cryo-EM", Proceedings of the National Academy of Sciences, 116(30), pp.15007~15012 (2019), Proceedings of the National Academy of Sciences[DOI]
  63. Nayim Sepay, "Anti-COVID-19 terpenoid from marine sources: A docking, admet and molecular dynamics study", Journal of Molecular Structure, 1228, pp.129433~ (2021), Elsevier BV[DOI]
  64. C. Sun, "SARSCoV- 2 and SARS-CoV spike-RBD structure and receptor binding comparison and potential implications on neutralizing antibody and vaccine development", bioRxiv. 2020.2002.2016.951723, ~ (2020)
  65. John H Van Drie, "Cryo-EM as a powerful tool for drug discovery", Bioorganic & Medicinal Chemistry Letters, 30(22), pp.127524~ (2020), Elsevier BV[DOI]
  66. J. A. Walker, "Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus", J. Virol, 68(2), pp.1213~1218 (1994)[DOI]
  67. Wilson Wong, "Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis", Nature Microbiology, 2(6) (2017), Springer Science and Business Media LLC[DOI]
  68. Daniel Wrapp, "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation", Science, 367(6483), pp.1260~1263 (2020), American Association for the Advancement of Science (AAAS)[DOI]
  69. Yan Wu, "A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2", Science, 368(6496), pp.1274~1278 (2020), American Association for the Advancement of Science (AAAS)[DOI]
  70. S. Xia, "The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin", Signal Transduct. Target. Ther., 5(1), pp.92~ (2020)[DOI]
  71. X. Xiong, "A thermostable, closed SARS-CoV-2 spike protein trimer", Nat. Struct. Mol. Biol., 27(10), pp.934~941 (2020)[DOI]
  72. K. M. Yip, "Breaking the next Cryo-EM resolution barrier – atomic resolution determination of proteins!", bioRxiv. 2020.2005.2021.106740, ~ (2020)
  73. Saman Zafar, "COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics", Pharmaceutics, 12(10), pp.945~ (2020), MDPI AG[DOI]
  74. Kai Zhang, "Gctf: Real-time CTF determination and correction", Journal of Structural Biology, 193(1), pp.1~12 (2016), Elsevier BV[DOI]
  75. Y. Zhang, "Single-particle cryo-EM structural studies of the beta2AR-Gs complex bound with a full agonist formoterol", Cell Discov., 6, pp.45~ (2020)[DOI]
  76. Z. R. Zhang, "A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2", Signal Transduct. Target. Ther., 5(1), pp.218~ (2020)[DOI]
  77. M. Zhang, "Cryo-EM structure of an activated GPCR-G protein complex in lipid nanodiscs", Nat. Struct. Mol. Biol., 28(3), pp.258~267 (2021)[DOI]
  78. Shawn Q Zheng, "MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy", Nature Methods, 14(4), pp.331~332 (2017), Springer Science and Business Media LLC[DOI]
  79. Jasenko Zivanov, "New tools for automated high-resolution cryo-EM structure determination in RELION-3", eLife, 7 (2018), eLife Sciences Publications, Ltd[DOI]

관련 논문AI추천

Advanced Cryo-Electron Microscopy Technology: High Resolution Structure of Macromolecules정정민, 정현석한국현미경학회 · Applied Microscopy2016 · 제46권 제1호Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target김수현, 배수영, 송창선, 이영민, 전현정, 홍재우, Choi Yeo-Ok, Taitt Afeisha S., Yeom Su Cheong대한면역학회 · Immune Network2021 · 제21권 제1호Toward High-Resolution Cryo-Electron Microscopy: Technical Review on Microcrystal-Electron Diffraction이상민, 정정민, 정현석한국현미경학회 · Applied Microscopy2017 · 제47권 제4호Advancements in Antiviral Drug Development: Comprehensive Insights into Design Strategies and Mechanisms Targeting Key Viral ProteinsCheng Wang, Hangyu Wang, Hongyan Wang, Jie Shen, Kangning Han, Linmiao Wei, Panpan Li, Shuai Wang, Yichen Shi한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제7호Recent Advances in Electron Crystallography이상민, 정정민, 정현석한국현미경학회 · Applied Microscopy2017 · 제47권 제3호COVID-19 Antiviral and Treatment Candidates: Current Status김다정, 김정기, 김지연, 박성규, Españo Erica대한면역학회 · Immune Network2021 · 제21권 제1호

이 간행물의 다른 논문 (3건)

Multispectral intravital microscopy for simultaneous bright-field and fluorescence imaging of the microvasculatureBarry G. H. Janssen, Mohamadreza Najiminaini, Yan Min Zhang, Parsa Omidi, Jeffrey J. L. Carsonpp. 1-12Capture silk scaffold production in the cribellar web spider이승민, 구본진, 박은아, 문명진, Yan Sunpp. 1-9Sensitivity of quantitative symmetry measurement algorithms for convergent beam electron diffraction technique홍승택, 소형섭, 이로운, Kim Kyou-Hyunpp. 1-9
원문 보기